Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms

  • Marius Ilie,
  • Shirin Khambata-Ford,
  • Christiane Copie-Bergman,
  • Lingkang Huang,
  • Jonathan Juco,
  • Veronique Hofman,
  • Paul Hofman
  • Article
  • Metrics
  • Comments
  • Media Coverage

Fig 1 is incorrect. The authors have provided a corrected version here.

thumbnail
Download:
Fig 1. Optimised protocols for PD-L1 IHC assays using the 22C3 antibody concentrate on the Dako ASL48 and VENTANA BenchMark ULTRA platforms.

PD-L1, programmed death ligand 1; IHC, immunohistochemistry; ASL48, Autostainer Link 48; DAB, 3,3’-diaminobenzidine tetrahydrochloride.

https://doi.org/10.1371/journal.pone.0186537.g001

Reference

  1. 1. Ilie M, Khambata-Ford S, Copie-Bergman C, Huang L, Juco J, Hofman V, et al. (2017) Use of the 22C3 anti–PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms. PLoS ONE 12(8): e0183023. https://doi.org/10.1371/journal.pone.0183023 pmid:28797130

Citation: Ilie M, Khambata-Ford S, Copie-Bergman C, Huang L, Juco J, Hofman V, et al. (2017) Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms. PLoS ONE 12(10): e0186537. https://doi.org/10.1371/journal.pone.0186537

Published: October 13, 2017

Copyright: © 2017 Ilie et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.